Salustri, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 245
EU - Europa 153
AS - Asia 108
AF - Africa 7
SA - Sud America 3
Totale 516
Nazione #
US - Stati Uniti d'America 243
SG - Singapore 42
SE - Svezia 39
IT - Italia 34
TW - Taiwan 21
CN - Cina 17
DE - Germania 17
IE - Irlanda 16
FI - Finlandia 11
ID - Indonesia 10
FR - Francia 8
IN - India 7
GB - Regno Unito 6
CZ - Repubblica Ceca 4
GR - Grecia 4
IR - Iran 4
BR - Brasile 3
CI - Costa d'Avorio 3
HK - Hong Kong 3
RU - Federazione Russa 3
CA - Canada 2
CH - Svizzera 2
JP - Giappone 2
UA - Ucraina 2
ZA - Sudafrica 2
AT - Austria 1
BE - Belgio 1
EE - Estonia 1
HU - Ungheria 1
JO - Giordania 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
RO - Romania 1
RS - Serbia 1
TZ - Tanzania 1
Totale 516
Città #
Chandler 68
Ashburn 29
Singapore 28
Dublin 16
Chicago 15
Boardman 14
New York 14
Jakarta 10
Rome 10
Bremen 6
Helsinki 6
Marseille 6
Princeton 6
Boston 5
Lappeenranta 5
Los Angeles 5
Milan 4
Abidjan 3
Brno 3
Cattolica 3
Dearborn 3
Hong Kong 3
Moscow 3
San Mateo 3
Washington 3
Andover 2
Ann Arbor 2
Busto Arsizio 2
Catania 2
Falkenstein 2
Jinan 2
Kish 2
Munich 2
Norwalk 2
Nuremberg 2
Pune 2
Redmond 2
Tokyo 2
Wilmington 2
Zurich 2
Amman 1
Ardabil 1
Augusta 1
Belgrade 1
Belpasso 1
Berlin 1
Boa Vista 1
Brdo 1
Brussels 1
Bucharest 1
Budapest 1
Cagliari 1
Cape Town 1
Changsha 1
Dar es Salaam 1
Edinburgh 1
Eunpyeong-gu 1
Islington 1
Johannesburg 1
Juiz de Fora 1
Kaili 1
London 1
Luoyang 1
Monmouth Junction 1
Nanjing 1
Nashville 1
Ottawa 1
Phoenix 1
Salò 1
Shanghai 1
Sturno 1
São Paulo 1
Tallinn 1
Tianjin 1
Toronto 1
Zhengzhou 1
Totale 337
Nome #
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 74
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 70
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 59
Graphene oxide-linezolid combination as potential new anti-tuberculosis treatment 55
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 54
Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2 52
Graphene–Curcumin Coatings Resistant to SARS-CoV-2 and Mycobacteria for the Production of Personal Protective Equipment 43
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin 37
SARS-CoV-2 Antigen Test Results to Infer Active or Non-Active Virus Replication Status in COVID-19 Patients 30
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 30
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 13
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 12
Totale 529
Categoria #
all - tutte 3.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 7 0
2020/202112 0 0 0 0 0 0 2 0 0 6 4 0
2021/202244 0 0 0 4 1 2 0 9 1 2 11 14
2022/2023206 20 19 13 29 4 21 10 19 23 23 22 3
2023/2024156 6 27 7 9 8 29 32 1 2 8 10 17
2024/202597 7 4 14 21 18 16 12 5 0 0 0 0
Totale 529